久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Company Profile

Year Established : 1989
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages : - Support of 50+ combination products to market launch - Top 25 majority of pharma/biotech companies in partnership with SHL - Over 33% compound annual shipment growth rate (CAGR) 2018-2024 - More than 142 million SHL autoinjectors reached patients worldwide in 2024
  • Contact Person :
  • Fax:

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions that enhance patients’ treatment experience and quality of life.

Our customers benefit from our proven track record and scalable, global manufacturing excellence, with locations across three continents and headquarters in Switzerland. By focusing on innovation, we challenge the status quo and shape the future of state-of-the-art drug delivery.

 

Company Video
Certificates/Standards
PharmaSources Customer Service